Clinical trial
Project to Accelerate the Diagnosis of TTR Amyloidosis by Use of Molecular Biology in First Intention
NCT03373370 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Project to Accelerate the Diagnosis of TTR Amyloidosis by Use of Molecular Biology in First Intention
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 17, 2017
- Completion date
- December 10, 2021
- Enrollment
- 560 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
diagnosis, idiopathic progressive neuropathy, polyneuropathy